AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.12 Cr | ₹4.42 Cr | ₹4.03 Cr | ₹6.76 Cr | ₹82 Cr |
What is the latest Contingent Liabilities ratio of AJANTA PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹8.12 Cr |
| Mar2024 | ₹4.42 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹6.76 Cr |
| Mar2021 | ₹82 Cr |
How is Contingent Liabilities of AJANTA PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.12 Cr | 83.71 | |
| Mar2024 | ₹4.42 Cr | 9.68 | |
| Mar2023 | ₹4.03 Cr | -40.38 | |
| Mar2022 | ₹6.76 Cr | -91.74 | |
| Mar2021 | ₹82 Cr | - | |
Compare Contingent Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹36,424.0 Cr | 0.5% | 5.6% | 16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 0.5% |
5.6% |
16.7% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses